How many genes are in the human genome? (The third in an irregular series of threads about #Bioinformatics.) Let’s start by restricting “gene” to mean “protein-coding gene.” For the moment, this number appears to be just under 20,000, far lower than it used to be 1/11
Exciting times at Betteromics! Come join us and learn more about all the amazing things you can do with our cutting edge AI-driven tools and promote your collaborations in life sciences and healthcare. #Betteromics
The recent paper of [Clark 2023 PNAS] finds that social status correlates across family lineage in a way that is consistent with genetic transmission. Is genetic transmission the only model that can produce this pattern? Let's take a look ...
https://t.co/RM8BLJbM3K
@Caroline_Bartma Non-resident tuition fees for international students in addition to the actual tuition they have to pay (mine used to be ~$5000 every quarter)
If anyone knows of any data science / pop gen positions in industry please get in touch! NYC area or remote.
@Color laid off ~50% of the company. Genomics R&D work basically out. Frustrating news, but proud of my contributions and grateful for all I learned & great colleagues.
This holiday season, @SecBlinken could affirm his support for the Diversity Visa program by withdrawing his appeals of the Gomez, Rai, and Goodluck orders. That single act would pave the way for nearly 20k DV2020 & DV2021 winners, their spouses, & children to be issued visas.
Of 100 drugs entering clinical development, only 8 or so are eventually approved. A sankey diagram nicely shows that even though phase II has the highest failure rate, phase I is actually where most drugs get dropped in absolute terms (data from BIO)
I'm incredibly excited about @Color's announcement today for our launch in Behavioral Health.
As with everything else @Color does, the model is designed to overcome cost and access barriers with a particular focus on public and population health.
Some keys to this are:
I'm excited to see the impressive new height GWAS out. But I'm concerned with the continuing pattern of a big chunk of the sample size coming from 23&me. with the 23&me data not being included in the summary data released. 1/n
1/13 If polygenic risk scores (PRS) are going to be used for patient care, they — and their limitations — need to make it onto a report. Report design matters for any impact PRS might eventually have. A 🧵